Mesothelioma, Secondary cancers
Results
Phase 3
This trial looked at adding a drug called ADI-PEG 20 to standard chemotherapy for mesothelioma.
It was for people with mesothelioma that started in the covering of the lungs (pleura).
The trial was open for people to join between 2017 and 2021. The team published the results in 2024.
Recruitment start: 1 August 2017
Recruitment end: 15 August 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Szlosarek
Polaris Pharmaceuticals Inc
Queen Mary University of London
Last reviewed: 19 Nov 2024
CRUK internal database number: 14751
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
